佐力药业：接受招商证券等投资者调研

Group 1 - Zhaoli Pharmaceutical announced an investor research meeting scheduled for January 15, 2026, from 10:00 to 11:30, where company executives will address investor inquiries [1] - The meeting will be attended by Mr. Feng Guofu, the company's director and executive vice president, and Ms. Wu Ying, the board secretary [1] Group 2 - The Ministry of Finance has imposed maximum penalties on a company for concealing key audit work papers and refusing to cooperate with investigations regarding billions in fraudulent accounting [1]